Pharma & Biopharma Manufacturing

Pall Corporation Launches Three New Allegro™ Connect Systems

Pall Corporation extends its bioprocessing solution portfolio with the launch of three new Allegro Connect Systems. In conjunction with Pall’s Allegr...

 September 28, 2022 | News

Lunit Showcases AI Solutions for Radiology at AOCR & KCR 2022

Lunit's demonstration focuses on how radiologists and AI solutions can create synergy through combined workflows Visitors invited to Lunit Demo Station ...

 September 22, 2022 | News

SCG Cell Therapy To Establish Cell Therapy Pilot cGMP Manufacturing Facility And R&D Centre In Singapore

With the support of the Singapore Economic Development Board (EDB), the hub comprises a pilot manufacturing facility and an R&D centre. SCG expect...

 September 21, 2022 | News

WuXi Biologics' Drug Substance and Drug Product Facilities Again Approved by U.S. FDA and EMA

After passing online Pre-Approval Inspection (PAI), WuXi Biologics received EMA GMP certificates for the commercial manufacturing of two biologics develope...

 September 20, 2022 | News

Sanyou ,KangaBio to accelerate antibody drug development and innovation

KangaBio, as a rising star biotechnology company, is committed to developing innovative prodrugs and providing innovative medicine to address unmet clinica...

 August 29, 2022 | News

Resilience Becomes Biomanufacturing Resource Partner for California Institute for Regenerative Medicine

National Resilience, Inc. (Resilience), a technology-focused biomanufacturing company dedicated to broadening access to complex medicines, was named b...

 August 24, 2022 | News

WuXi STA Breaks Ground for New Pharmaceutical Manufacturing Facility

First announced in June 2021, this site will be WuXi STA's second facility in the United States, offering expanded capacity and greater flexibili...

 August 17, 2022 | News

Everest Medicines Enters into Agreement with Gilead Sciences for Trodelvy in Asia Territories

Broadens development and access to Trodelvy for patients in Greater China and certain Asia Pacific Markets Strengthens balance sheet and streaml...

 August 16, 2022 | News

WuXi ATU Announces Licensing Agreement with Janssen for TESSA™ Technology

WuXi ATU will license to Janssen its TESSA™ technology, a high-performance system that can produce 10 times more adeno-associated viral (AAV) vectors...

 August 12, 2022 | News

Polyplus Introduces Transgene Plasmid Engineering Services for Optimized Viral Vector Manufacturing

Following the early 2022 acquisition of e-Zyvec, integration activities have focused on providing a deeper level of solutions support to customers. Using t...

 August 03, 2022 | News

Daewoong Pharmaceutical Gets First Korean US FDA Fast-Track for New Idiopathic Pulmonary Fibrosis Drug

As many Korean pharmaceutical manufacturers are currently attempting to develop new drugs for idiopathic pulmonary fibrosis, Daewoong Pharmaceutical's new ...

 July 21, 2022 | News

WuXi STA Opens a New Large Scale Continuous Manufacturing Plant

 WuXi STA, a subsidiary of WuXi AppTec, announced that it has opened a new continuous manufacturing (flow chemistry) plant at its Changzhou campus in ...

 July 20, 2022 | News

Merck Breaks Ground on Company’s First Lateral Flow Membrane Production Facility

New facility to manufacture the company’s Hi-Flow™ Plus lateral flow membrane used in rapid diagnostic test kit manufacturing, including Covi...

 July 18, 2022 | News

TFBS will leverage the scale-X™ carbo mid-scale fixed-bed bioreactor from Univercells Technologies

 TFBS Bioscience Inc., the leading GMP viral vector contract development and manufacturing organization in the Asia-Pacific region providing the first...

 July 15, 2022 | News


Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close